These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10352189)

  • 21. [20 years' experience with the treatment of idiopathic membranous glomerulopathy. Retrospective study].
    Knotoková V; Nĕmecek K
    Cas Lek Cesk; 1990 Mar; 129(10):292-7. PubMed ID: 2340548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted?
    Honkanen E; Törnroth T; Grönhagen-Riska C; Sankila R
    Clin Nephrol; 1994 Mar; 41(3):127-34. PubMed ID: 8187353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis?
    Davenport A; Maciver AG; Hall CL; MacKenzie JC
    Clin Nephrol; 1994 May; 41(5):271-6. PubMed ID: 8050206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membranous nephropathy. Long-term follow-up and association with neoplasia.
    Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
    Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapsing idiopathic membranous nephropathy.
    Manos J; Short CD; Acheson EJ; Dyer P; Lawler W; Mallick NP; Williams G
    Clin Nephrol; 1982 Dec; 18(6):286-90. PubMed ID: 7151346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy?
    Ponticelli C; Passerini P
    J Nephrol; 2010; 23(2):156-63. PubMed ID: 20213607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine A in treatment of membranous lupus nephropathy.
    Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
    Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety.
    Palla R; Cirami C; Panichi V; Bianchi AM; Parrini M; Grazi G
    Clin Nephrol; 1991 Mar; 35(3):98-104. PubMed ID: 2032403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
    Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of adult patients with minimal urinary abnormalities and normal renal function.
    Shu KH; Ho WL; Lu YS; Cheng CH; Wu MJ; Lian JD
    Clin Nephrol; 1999 Jul; 52(1):5-9. PubMed ID: 10442489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membranous nephropathy: a 19 year prospective study in 51 patients.
    Hay NM; Bailey RR; Lynn KL; Robson RA
    N Z Med J; 1992 Dec; 105(947):489-91. PubMed ID: 1461605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
    Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
    J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T
    N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.